Postoperative pancreatic fistula after cytoreductive surgery and perioperative intraperitoneal chemotherapy: Incidence, risk factors, management, and clinical sequelae

Annals of Surgical Oncology

Volumn 17, Issue 5, 2010, Pages 1302-1310

  Saxena, Akshat ^a   Chua, Terence C ^a   Yan, Tristan D ^a   Morris, David L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; OCTREOTIDE;

ADULT; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CONSERVATIVE TREATMENT; CYTOREDUCTIVE SURGERY; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; OVARY CARCINOMA; PANCREAS FISTULA; PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; PERIOPERATIVE PERIOD; PERITONEUM MESOTHELIOMA; RISK FACTOR; SPLENECTOMY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PANCREATIC FISTULA; PERIOPERATIVE CARE; PERITONEAL NEOPLASMS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PSEUDOMYXOMA PERITONEI; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77952097197     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0898-2     Document Type: Article

References (34)

1. TD Yan EA Brun CA Cerruto, et al. 2007 Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma Ann Surg Oncol 14 41 49 10.1245/s10434-006-9169-7 17039392 (Pubitemid 44954269)
2. S Gonzalez-Moreno PH Sugarbaker 2004 Right hemicolectomy does not confer a survival advantage in patients with mucinous carcinoma of the appendix and peritoneal seeding Br J Surg 91 304 311 10.1002/bjs.4393 14991630 (Pubitemid 38375769)
3. O Glehen F Kwiatkowski PH Sugarbaker, et al. 2004 Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study J Clin Oncol 22 3284 3292 10.1200/JCO.2004.10.012 15310771 (Pubitemid 41103684)
4. D Elias JH Lefevre J Chevalier, et al. 2009 Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 681 685 10.1200/JCO.2008.19. 7160 19103728
5. VJ Verwaal S van Ruth E de Bree, et al. 2003 Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737 3743 10.1200/JCO.2003.04.187 14551293 (Pubitemid 46606227)
6. N Gusani S Cho C Colovos, et al. 2008 Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 754 763 10.1245/s10434-007-9701-4 18080166
7. AD Stephens R Alderman D Chang, et al. 2000 Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative chemotherapy using the Coliseum technique Ann Surg Oncol 6 790 796 10.1007/s10434-999-0790-0
8. O Glehen D Osinsky E Cotte, et al. 2003 Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: Morbidity and mortality analysis of 216 consecutive procedures Ann Surg Oncol 10 863 869 10.1245/ASO.2003.01.018 14527903 (Pubitemid 40486849)
9. D Elias D Goere F Blot, et al. 2007 Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43°C after compete cytoreductive surgery: Mortality and morbidity in 106 consecutive patients Ann Surg Oncol 14 1818 1824 10.1245/s10434-007-9348-1 17356950 (Pubitemid 46870938)
10. Saxena A, Yan TD, Morris DL. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures. Eur J Surg Oncol. 2009 (in press).
11. S Kusamura D Baratti A Antonucci, et al. 2007 Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg Oncol 14 3443 3452 10.1245/s10434-007-9551-0 17909918 (Pubitemid 350160119)
12. T Tansung PH Sugarbaker 1995 Managment of pancreatitis due to pancreatic injury in cytoreductive surgery Reg Cancer Treat 8 180 184 (Pubitemid 26172209)
13. ASA. New classification of physical status. Anesthesiology. 1963;24.
14. P Jacquet PH Sugarbaker 1996 Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 359 374 8849962 (Pubitemid 26130826)
15. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg 221 29 42 7826158
16. TD Yan M Links S Fransi, et al. 2007 Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy-a journey to becoming a Nationally Funded Peritonectomy Center Ann Surg Oncol 14 2270 2280 10.1245/s10434-007-9406-8 17464543 (Pubitemid 47174916)
17. C Bassi C Dervenis G Butturini, et al. 2005 Postoperative pancreatic fistula: An International Study Group (ISGPF) definition Surgery 138 8 13 10.1016/j.surg.2005.05.001 16003309 (Pubitemid 40933766)
18. SA Ahmad J Kim JJ Sussman, et al. 2004 Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion Ann Surg Oncol 11 387 392 10.1245/ASO.2004.09.007 15070598 (Pubitemid 40486748)
19. E Akaishi F Teixeira M Katayama, et al. 2009 Peritonectomy for peritoneal carcinomatosis: Long-term outcomes from a single Brazilian institution World J Surg 33 835 839 10.1007/s00268-008-9880-6 19169741
20. B Chand RM Walsh J Ponsky F Brody 2001 Pancreatic complications following laparoscopic splenectomy Surg Endosc 15 1273 1276 10.1007/s004640080054 11727132 (Pubitemid 33035402)
21. JO Pelz J Doerfer A Dimmler W Hohenberger T Meyer 2006 Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations BMC Cancer 6 162 10.1186/1471-2407-6-162 16792796 (Pubitemid 44269434)
22. BK Goh YM Tan YF Chung, et al. 2008 Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: A 21-year experience at a single institution Arch Surg 143 956 965 10.1001/archsurg.143.10.956 18936374
23. KK Kazanjian OJ Hines G Eibl HA Reber 2005 Management of pancreatic fistulas after pancreaticoduodenectomy: results in 437 consecutive patients Arch Surg 140 849 854 10.1001/archsurg.140.9.849 16172293 discussion 854-846 (Pubitemid 41345981)
24. GV Aranha JM Aaron M Shoup J Pickleman 2006 Current management of pancreatic fistula after pancreaticoduodenectomy Surgery 140 561 568 10.1016/j.surg.2006.07.009 17011903 discussion 568-569 (Pubitemid 44442346)
25. V Pannegeon P Pessaux A Sauvanet, et al. 2006 Pancreatic fistula after distal pancreatectomy: Predictive risk factors and value of conservative treatment Arch Surg 141 1071 1076 10.1001/archsurg.141.11.1071 17116799 discussion 1076 (Pubitemid 44790531)
26. J Li-Ling M Irving 2001 Somatostatin and octreotide in the prevention of postoperative pancreatic complications and the treatment of enterocutaneous pancreatic fistulas: A systematic review of randomized controlled trials Br J Surg 88 190 199 10.1046/j.1365-2168.2001.01659.x 11167865 (Pubitemid 32142703)
27. M Ridgeway B Stabile 1996 Surgical managment and treatment of pancreatic fistulas Surg Clin North Am 76 1159 1173 10.1016/S0039-6109(05)70504-1 8841370 (Pubitemid 26315247)
28. S Abou-Assi K Craig SJ O'Keefe 2002 Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study Am J Gastroenterol 97 2255 2262 10.1111/j.1572-0241.2002. 05979.x 12358242
29. F Kalfarentzos J Kehagias N Mead K Kokkinis CA Gogos 1997 Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial Br J Surg 84 1665 1669 10.1002/bjs.1800841207 9448611 (Pubitemid 27519591)
30. PE Marik GP Zaloga 2004 Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis BMJ 328 7453 1407 10.1136/bmj.38118.593900.55 15175229
31. J Esquivel J Vidal-Jove MA Steves PH Sugarbaker 1993 Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy Surgery 113 631 636 8506520 (Pubitemid 23176305)
32. KC Conlon D Labow D Leung, et al. 2001 Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection Ann Surg 234 487 493 10.1097/00000658-200110000-00008 11573042 discussion 493-484 (Pubitemid 32946711)
33. CJ Yeo JL Cameron KD Lillemoe, et al. 2000 Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial Ann Surg 232 419 429 10.1097/00000658-200009000-00014 10973392
34. KD Lillemoe JL Cameron MP Kim, et al. 2004 Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial J Gastrointest Surg 8 766 772 10.1016/j.gassur.2004.06.011 15531229 discussion 772-64 (Pubitemid 41115729)